Moolec Science SA (MLECW) Stock Price & Analysis
Moolec Science SA (MLECW) closed at USD 0.01 on Thursday, October 15, 2026, up 24.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.01; the Oct 15, 2026 session ranged USD 0.01–0.01 on volume of 1,938 shares. Market capitalization is —, with a 52-week range of USD 0.01–0.01 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:11 UTC.
Also available as compact Markdown for AI agents: nexqual.com/MLECW.md
Key facts (MLECW)
- Analysts: None.
Analysts (MLECW)
Consensus None.
Key Statistics (as of October 16, 2026 at 05:11 UTC)
| Price | USD 0.01 |
|---|---|
| Change | ▲ 24.00% (up) |
| Previous Close | USD 0.01 |
| Open | USD 0.01 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0.01 – 0.01 |
| Volume | 1,938 shares |
| Market Cap | — |
| Exchange | NCM |
Analyst Ratings (MLECW)
Wall Street analysts rate MLECW "None", per Nexqual as of October 16, 2026 at 05:11 UTC.
| Consensus Rating | None |
|---|
Earnings (MLECW)
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Financials & Fundamentals (MLECW)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Financial Health Score (MLECW)
Nexqual rates Moolec Science SA's overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:11 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Leadership (MLECW)
Moolec Science SA is led by Alejandro Antalich (age 51), Chief Executive Officer, per Nexqual as of October 16, 2026 at 05:11 UTC.
| Chief Executive Officer | Alejandro Antalich (age 51) |
|---|---|
| Co-Founder & Chief Product Officer | Henk Hoogenkamp (age 37) |
| Chief Financial Officer | Valeria Falottico (age 43) |
| Chief Technology Officer | Paola Díaz Dellavalle (age 49) |
Major Backers & Investors (MLECW)
Notable institutional backers of Moolec Science SA include Linden Advisors LP, Hartree Partners, LP, Aristeia Capital, LLC, according to Nexqual as of October 16, 2026 at 05:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Linden Advisors LP | 5.35% |
| Hartree Partners, LP | 3.71% |
| Aristeia Capital, LLC | 2.97% |
| Davidson Kempner Capital Management LP | 2.25% |
| Clear Street Group Inc. | 1.79% |
| MAI Capital Management | 0.9% |
| Johnson Investment Counsel Inc | 0.45% |
| Jane Street Group, LLC | 0.35% |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MLEC | Moolec Science SA | USD 1.87 | ▲ 9.42% |
| CDIOW | Cardio Diagnostics Holdings, Inc. | USD 0.01 | ▼ 28.09% |
| ICUCW | SeaStar Medical Holding Corporation | USD 0.02 | ▲ 0% |
| REVBW | Revelation Biosciences, Inc. | USD 0.01 | ▲ 1.56% |
| JSPRW | Jasper Therapeutics, Inc. | USD 0 | ▼ 84.62% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:11 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt